CT
CRL icon

Colonial Trust’s Charles River Laboratories CRL Stock Holding History

Colonial Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59K Hold
7
– – ﹤0.01% 1049
2026
Q1 		$1.21K Hold
7
– – ﹤0.01% 1055
2025
Q4 		$1.4K Hold
7
– – ﹤0.01% 1016
2025
Q3 		$1.09K Hold
7
– – ﹤0.01% 1025
2025
Q2 		$1.06K Sell
7
-50
-88% -$6.67K ﹤0.01% 1021
2025
Q1 		$8.56K Sell
57
-1
-2% -$168 ﹤0.01% 775
2024
Q4 		$10.7K Sell
58
-204
-78% -$39.3K ﹤0.01% 931
2024
Q3 		$51.6K Buy
262
+225
+608% +$46.8K 0.01% 546
2024
Q2 		$7.67K Hold
37
– – ﹤0.01% 798
2024
Q1 		$9.97K Hold
37
– – ﹤0.01% 762
2023
Q4 		$8.84K Sell
37
-26
-41% -$5.11K ﹤0.01% 736
2023
Q3 		$12.9K Buy
63
+12
+24% +$2.46K ﹤0.01% 674
2023
Q2 		$10.7K Buy
51
+26
+104% +$5.17K ﹤0.01% 691
2023
Q1 		$4.95K Sell
25
-26
-51% -$5.89K ﹤0.01% 756
2022
Q4 		$11.4K Buy
+51
New +$11.1K ﹤0.01% 654

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Colonial Trust's CRL Position: Q2 2026 in Review

Colonial Trust held its Charles River Laboratories (CRL) position steady in Q2 2026 at 7 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Colonial Trust first reported a position in CRL in Q4 2022 and has held it in 15 quarters since. The position peaked at $51.6K in Q3 2024. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Colonial Trust held 7 shares of Charles River Laboratories worth $1.59K as of Q2 2026.
  • Colonial Trust left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #1049 holding.
  • Colonial Trust first reported a position in Charles River Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Colonial Trust's Charles River Laboratories position peaked at $51.6K in Q3 2024.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.